Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More
BLISS GVS PHARMA TEVA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
BLISS GVS PHARMA Mar-23 |
TEVA PHARMA Dec-13 |
BLISS GVS PHARMA/ TEVA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 91 | 3,483 | - | |
Low | Rs | 67 | 3,026 | - | |
Sales per share (Unadj.) | Rs | 72.2 | 1,998.8 | - | |
Earnings per share (Unadj.) | Rs | 7.4 | 124.9 | - | |
Cash flow per share (Unadj.) | Rs | 9.2 | 286.4 | - | |
Dividends per share (Unadj.) | Rs | 0.50 | 109.31 | - | |
Avg Dividend yield | % | 0.6 | 3.4 | 18.8% | |
Book value per share (Unadj.) | Rs | 84.0 | 2,220.3 | - | |
Shares outstanding (eoy) | m | 104.15 | 848.00 | - | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 1.6 | 67.5% | |
Avg P/E ratio | x | 10.8 | 26.1 | 41.3% | |
P/CF ratio (eoy) | x | 8.7 | 11.4 | 76.2% | |
Price / Book Value ratio | x | 0.9 | 1.5 | 64.4% | |
Dividend payout | % | 6.8 | 87.5 | 7.8% | |
Avg Mkt Cap | Rs m | 8,262 | 2,759,528 | 0.3% | |
No. of employees | `000 | NA | 44.9 | 0.0% | |
Total wages/salary | Rs m | 862 | 0 | - | |
Avg. sales/employee | Rs Th | 0 | 37,712.8 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 2,355.9 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 7,516 | 1,695,000 | 0.4% | |
Other income | Rs m | 178 | 0 | - | |
Total revenues | Rs m | 7,694 | 1,695,000 | 0.5% | |
Gross profit | Rs m | 1,173 | 464,177 | 0.3% | |
Depreciation | Rs m | 187 | 137,008 | 0.1% | |
Interest | Rs m | 104 | 33,293 | 0.3% | |
Profit before tax | Rs m | 1,061 | 293,876 | 0.4% | |
Minority Interest | Rs m | 0 | 1,335 | 0.0% | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | -192,913 | -0.0% | |
Tax | Rs m | 293 | -3,588 | -8.2% | |
Profit after tax | Rs m | 767 | 105,885 | 0.7% | |
Gross profit margin | % | 15.6 | 27.4 | 57.0% | |
Effective tax rate | % | 27.7 | -1.2 | -2,265.3% | |
Net profit margin | % | 10.2 | 6.2 | 163.4% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 6,974 | 1,144,797 | 0.6% | |
Current liabilities | Rs m | 1,933 | 998,360 | 0.2% | |
Net working cap to sales | % | 67.1 | 8.6 | 776.4% | |
Current ratio | x | 3.6 | 1.1 | 314.7% | |
Inventory Days | Days | 39 | 91 | 42.6% | |
Debtors Days | Days | 1,871 | 96 | 1,950.2% | |
Net fixed assets | Rs m | 4,562 | 553,624 | 0.8% | |
Share capital | Rs m | 104 | 4,172 | 2.5% | |
Net worth | Rs m | 8,750 | 1,882,824 | 0.5% | |
Long term debt | Rs m | 407 | 866,691 | 0.0% | |
Total assets | Rs m | 11,535 | 3,873,619 | 0.3% | |
Interest coverage | x | 11.2 | 9.8 | 114.3% | |
Debt to equity ratio | x | 0 | 0.5 | 10.1% | |
Sales to assets ratio | x | 0.7 | 0.4 | 148.9% | |
Return on assets | % | 7.6 | 3.6 | 210.2% | |
Return on equity | % | 8.8 | 5.6 | 155.9% | |
Return on capital | % | 12.7 | 4.9 | 257.8% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 343 | 270,095 | 0.1% | |
From Investments | Rs m | -78 | -95,706 | 0.1% | |
From Financial Activity | Rs m | -249 | -323,998 | 0.1% | |
Net Cashflow | Rs m | 30 | -149,608 | -0.0% |
Compare BLISS GVS PHARMA With: ADCOCK INGRAM (S. Africa) MYLAN (US) ACTAVIS (US)
Compare BLISS GVS PHARMA With: BDH INDUS. VIVIMED LABS SHILPA MEDICARE AJANTA PHARMA CAPLIN POINT
After opening the day on positive note, Indian share markets reversed the trend as the session progressed and ended lower.